tirzepatide and glp-1 Understand GLP-1/GIP Dual Agonist Its Effect on Current Weight Loss Therapy GLP-1 and Inflammation: How These
Description
Initially approved for type 2 diabetes, Mounjaro has shown promising results in promoting weight loss
doi: 10.1177/2333794X19891305 [DOI] [PMC free article] [PubMed] [Google Scholar] 6
Interestingly, clinical observations suggest that the GIP component may help mitigate some of the gastrointestinal side effects that some patients experience on older regimens
Dosage How quickly you see results depends partly on how your body handles each dose increase
These medications help reduce hunger and increase feelings of fullness
This informational overview was prepared by an independent digital publisher
